ClearBridge Investments
BBIO icon

ClearBridge Investments’s BridgeBio Pharma BBIO Stock Holding History

ClearBridge Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74M Buy
993,103
+41,903
+4% +$2.93M 0.06% 267
2026
Q1 		$70.6M Buy
951,200
+452,871
+91% +$32.8M 0.06% 258
2025
Q4 		$38.1M Buy
498,329
+5,266
+1% +$346K 0.03% 361
2025
Q3 		$25.6M Buy
493,063
+308,296
+167% +$15M 0.02% 416
2025
Q2 		$7.98M Buy
+184,767
New +$6.72M 0.01% 513

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

ClearBridge Investments's BBIO Position: Q2 2026 in Review

ClearBridge Investments increased its BridgeBio Pharma (BBIO) stake by 4.4% in Q2 2026, buying an estimated $2.93M and bringing the position to 993,103 shares worth $74M. The position accounts for 0.06% of the portfolio, ranked #267.

ClearBridge Investments first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • ClearBridge Investments held 993,103 shares of BridgeBio Pharma worth $74M as of Q2 2026.
  • ClearBridge Investments bought 41,903 BridgeBio Pharma shares in Q2 2026, an estimated $2.93M.
  • BridgeBio Pharma made up 0.06% of ClearBridge Investments's portfolio in Q2 2026, its #267 holding.
  • ClearBridge Investments first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.